Peginterferon alfa and ribavirin for the treatment of mild chronic hepatitis C

Technology appraisal guidance
Reference number: TA106
Published: 23 August 2006
Last updated: 27 November 2013

Download guidance (PDF)

7 Related guidance

7.1 NICE has issued the following related technology appraisal guidance.

Adefovir dipivoxil and peginterferon alfa-2a for the treatment of chronic hepatitis B. NICE technology appraisal guidance no. 96 (2006).
Interferon alfa (pegylated and non-pegylated) and ribavirin for the treatment of chronic hepatitis C. NICE technology appraisal guidance no. 75 (2004).